Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy.
Vicenti I, Basso M, Pirola N, Bragato B, Rossi MC, Giobbia M, Pascoli S, Vinci A, Caputo S, Varasi I, Biba C, Fiaschi L, Zazzi M, Parisi SG. Vicenti I, et al. Among authors: caputo s. Vaccines (Basel). 2023 Apr 20;11(4):871. doi: 10.3390/vaccines11040871. Vaccines (Basel). 2023. PMID: 37112782 Free PMC article.
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
Clemente T, Diotallevi S, Minisci D, Di Biagio A, Lolatto R, Attala L, Cenderello G, Siribelli A, Muccini C, Lo Caputo S, Tavio M, Papaioannu Borjesson R, Giacomelli A, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. Among authors: lo caputo s. J Antimicrob Chemother. 2024 Dec 27:dkae465. doi: 10.1093/jac/dkae465. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39727173
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort.
d'Arminio Monforte A, Tavelli A, Quiros-Roldan E, Fabbiani M, Ferrara M, Lo Caputo S, Squillace N, Rusconi S, Ponzano M, Bovis F, Antinori A, Saracino A, Cozzi-Lepri A. d'Arminio Monforte A, et al. Among authors: lo caputo s. HIV Med. 2024 Dec 2. doi: 10.1111/hiv.13740. Online ahead of print. HIV Med. 2024. PMID: 39618291
Disparities in tuberculosis diagnostic delays between native and migrant populations in Italy: A multicenter study.
Di Gennaro F, Cotugno S, Guido G, Cavallin F, Pisaturo M, Onorato L, Zimmerhofer F, Pipitò L, De Iaco G, Bruno G, Fasano M, Pontarelli A, Botta A, Iacovazzi T, Lattanzio R, Di Bari V, Panico G, Libertone R, Monari C, Musto A, Niglio M, De Gregorio F, Alessio L, Gualano G, Minniti S, Buccoliero GB, Santantonio T, Lo Caputo S, Carbonara S, Cascio A, Parrella R, Palmieri F, Coppola N; TB Delay Working Group; Saracino A. Di Gennaro F, et al. Among authors: lo caputo s. Int J Infect Dis. 2025 Jan;150:107279. doi: 10.1016/j.ijid.2024.107279. Epub 2024 Oct 28. Int J Infect Dis. 2025. PMID: 39477007 Free article.
[Interpretation of results from high-throughput sequencing for genetic diseases: implementation of national homogenization in France].
Gorokhova S, Rouzier C, Acquaviva-Bourdain C, Baert-Desurmont S, Caputo S, Chatron N, Coulet F, Doco-Fenzy M, Keren B, Le Marechal C, Nicolas G, Procaccio V, Richard P, Romanet P, Snanoudj S, Muller J, Krahn M, Saugier-Veber P. Gorokhova S, et al. Among authors: caputo s. Med Sci (Paris). 2024 Oct;40(10):767-769. doi: 10.1051/medsci/2024104. Epub 2024 Oct 25. Med Sci (Paris). 2024. PMID: 39450962 French. No abstract available.
Markers of Metabolic Abnormalities in Vitiligo Patients.
Papaccio F, Ottaviani M, Truglio M, D'Arino A, Caputo S, Pacifico A, Iacovelli P, Di Nardo A, Picardo M, Bellei B. Papaccio F, et al. Among authors: caputo s. Int J Mol Sci. 2024 Sep 23;25(18):10201. doi: 10.3390/ijms251810201. Int J Mol Sci. 2024. PMID: 39337683 Free PMC article.
Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Moradi Tuchayi A, Lawhn-Heath C, Wang T, Carducci MA, Pomper MG, Paller CJ, Czernin J, Solnes LB, Hope TA, Sartor O, Calais J, Gafita A. Murthy V, et al. Among authors: caputo s. J Nucl Med. 2024 Nov 1;65(11):1740-1744. doi: 10.2967/jnumed.124.267816. J Nucl Med. 2024. PMID: 39327018 Clinical Trial.
524 results